Skip to main content
. 2020 Nov 18;87(4):2146–2151. doi: 10.1111/bcp.14599

FIGURE 1.

FIGURE 1

Median latency times for the symptoms in the cases reported to Lareb. GD: general disorders and administration site conditions; NSD: nervous system disorders; GID: gastrointestinal disorders; MCD: musculoskeletal and connective tissue disorders; SOCs: system organ classes